STK11 and non-small cell lung carcinoma: Phenformin was previously found to have superior efficacy against LKB1-deficient NSCLC cells [48], and thus our observation that the action of mandelalide A may be independent of LKB1 status provides a starting point for further investigation of ATP synthase inhibitors against TKI-resistant NSCLC cell types.